The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death (Q43996569)

28 November 2017

title

The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death (English)

1 reference

28 November 2017

3

Andrea Cozzi

1 reference

28 November 2017

Flavio Moroni

1

1 reference

28 November 2017

Sabina Attucci

2

1 reference

28 November 2017

Elena Meli

4

1 reference

28 November 2017

Roberta Picca

5

1 reference

28 November 2017

Mark A Scheideler

6

1 reference

28 November 2017

Roberto Pellicciari

7

1 reference

28 November 2017

Christian Noe

8

1 reference

28 November 2017

Iran Sarichelou

9

1 reference

28 November 2017

Domenico E Pellegrini-Giampietro

10

1 reference

28 November 2017

publication date

1 May 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

42

1 reference

28 November 2017

issue

6

1 reference

28 November 2017

page(s)

741-751

1 reference

Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Prostaglandins stimulate calcium-dependent glutamate release in astrocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 r

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

A quantitative pharmacological analysis of some excitatory amino acid receptors in the mouse neocortex in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

General anaesthetics inhibit the responses induced by glutamate receptor agonists in the mouse cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Anticonvulsant actions of LY 367385 ((+)-2-methyl-4-carboxyphenylglycine) and AIDA ((RS)-1-aminoindan-1,5-dicarboxylic acid).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Functional coupling between ryanodine receptors and L-type calcium channels in neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Cerebral hypoxia: some new approaches and unanswered questions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Calcium: still center-stage in hypoxic-ischemic neuronal death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Direct effects of metabotropic glutamate receptor compounds on native and recombinant N-methyl-D-aspartate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Calcium accumulation and neuronal damage in the rat hippocampus following cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Analysis of agonist and antagonist activities of phenylglycine derivatives for different cloned metabotropic glutamate receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

The mGlu receptor ligand (S)-4C3HPG protects neurons after global ischaemia in gerbils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

G-protein-independent signaling mediated by metabotropic glutamate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

GM1 ganglioside reduces ischemia-induced excitatory amino acid output: a microdialysis study in the gerbil hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Sulfate esters of hydroxy amino acids as stereospecific glutamate receptor agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Biochemical and electrophysiological studies on (S)-(+)-2-(3'-carboxybicyclo(1.1.1)pentyl)-glycine (CBPG), a novel mGlu5 receptor agonist endowed with mGlu1 receptor antagonist activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Pharmacological characterization of metabotropic glutamate receptors potentiating NMDA responses in mouse cortical wedge preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Activation of group I metabotropic glutamate receptors produces a direct excitation and disinhibition of GABAergic projection neurons in the substantia nigra pars reticulata.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Excitatory amino acid neurotoxicity and neurodegenerative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Presynaptic mGlu1 type receptors potentiate transmitter output in the rat cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Activation of metabotropic glutamate receptor subtype mGluR1 contributes to post-traumatic neuronal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

The release and uptake of excitatory amino acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Excitotoxic amino acids and neuropsychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

The glycine antagonist and free radical scavenger 7-Cl-thio-kynurenate reduces CA1 ischemic damage in the gerbil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

1-Aminoindan-1,5-dicarboxylic acid and (S)-(+)-2-(3'-carboxybicyclo[1.1.1] pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

1-Aminoindan-1,5-dicarboxylic acid: a novel antagonist at phospholipase C-linked metabotropic glutamate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

(S)-(+)-2-(3'-carboxybicyclo[1.1.1]pentyl)-glycine, a structurally new group I metabotropic glutamate receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

The metabotropic glutamate receptors: structure and functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Reversal of glutamate excitotoxicity by activation of PKC-associated metabotropic glutamate receptors in cerebellar granule cells relies on NR2C subunit expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Pathophysiology of acute ischaemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Metabotropic glutamate receptors in brain function and pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Protective effect of group I metabotropic glutamate receptor activation against hypoxic/hypoglycemic injury in rat hippocampal slices: timing and involvement of protein kinase C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Diazepam, given postischemia, protects selectively vulnerable neurons in the rat hippocampus and striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Use of 3H-muscimol for GABA receptor studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Actions of phenylglycine analogs at subtypes of the metabotropic glutamate receptor family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

L-2-amino-4-phosphonobutyrate (L-AP4) is an agonist at the type IV metabotropic glutamate receptor which is negatively coupled to adenylate cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

A pharmacological characterization of the mGluR1α subtype of the metabotropic glutamate receptor expressed in a cloned baby hamster kidney cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

Reversible middle cerebral artery occlusion without craniectomy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900033-3

10.1016/S0028-3908(02)00033-3

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference